Cerebral amyloid angiopathy

There are 191 papers on cerebral amyloid angiopathy in aging research: 1 trial and 117 observational studies in people, 48 in animals, 22 reviews. The newest story, Nov 6, 2026: “Age-related brain protein changes linked to poorer cognition”.

Disease

191 papers study it51 more mention it79 findings

MeSH

8 new papers in 30 daysSee all 242 papers on cerebral amyloid angiopathy

At a glance

Cerebral amyloid angiopathy is linked with worse global cognition, dementia, worse gait and cerebral microbleeds in human studies. A mouse study reports that microglial transplantation protects against angiopathy in Alzheimer's disease mice; another reports that rapamycin reduces it in symptomatic hAPP mice when treatment starts after disease onset.

79 findings in 61 papers from 2002 to 2026, 10 of them since April 2026

“Cerebral amyloid angiopathy exhibited a striking ε4 dose-response (OR = 5.76, 95% CI: 4.20-7.96, p < 0.001; for ε4/ε4 compared to ε3/ε3)”
Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4Research square2026doi:10.21203/rs.3.rs-9044264/v1
  • Human trial1
  • Humans117
  • Animals48
  • In silico2

Interventions

5

Antihypertensive agents

no changein humans1

1 study
  1. Antihypertensive agents were not clearly linked with cerebral amyloid angiopathy in humans (autopsy cohort).

    “No significant relationship was detected between infarction (presence, type, number and size), lacunes or cerebral amyloid angiopathy and antihypertensive medication use.”

    Humansautopsy cohort

    Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals

    Neuropathology and applied neurobiology

More on Antihypertensive agents

Microglial transplantation

downin mice1

1 study
  1. Microglial transplantation protects against cerebral amyloid angiopathy in Alzheimer's disease mice.

    “These results indicate the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification.”

    Animalsin Alzheimer's disease micebrain

    Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice

    Cell reports

More on Microglial transplantation

Cpg odn 2006

downin Saimiri1

1 study
  1. Cpg odn 2006 decreases cerebral amyloid angiopathy in Saimiri (sporadic Alzheimer's disease pathology).

    “resulting in efficient amelioration of both CAA and tau Alzheimer's disease-related pathologies in association with behavioural improvements”

    Animalssporadic Alzheimer's disease pathology

    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys

    Brain : a journal of neurology

More on Cpg odn 2006

Exercise

no changein mice1

1 study
  1. Exercise showed no clear effect on cerebral amyloid angiopathy in mice (Tg-SwDI mice).

    “At all running levels, CAA pathology in Tg-SwDI mice was not significantly altered”

    AnimalsTg-SwDI mice

    Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy

    Journal of neuroinflammation

More on Exercise

Rapamycin

downin mice1

1 study
  1. Rapamycin decreases cerebral amyloid angiopathy in mice (treatment started after disease onset in symptomatic hAPP mice).

    “reduced cerebral amyloid angiopathy and microhemorrhages”

    Animalstreatment started after disease onset in symptomatic hAPP micebrain

    Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

More on Rapamycin

Effects

11

Perceptual speed

downin humans1

1 study
  1. Cerebral amyloid angiopathy is linked with worse perceptual speed in the presence of elevated iron compared to low iron (p = 0.03).

    “CAA had steeper decline in perceptual speed when elevated iron was present compared to when low iron was present (p = 0.03).”

    Humansin the presence of elevated iron compared to low ironn = 626

    Cerebral amyloid angiopathy, brain iron concentrations, and cognitive decline in older people

    Acta neuropathologica

Global cognition

downin humans1

1 study
  1. Cerebral amyloid angiopathy is linked with worse global cognition in humans (mean follow-up = 7.7 years) (p < 0.04).

    “both CAA and elevated iron were independently associated with faster annual rates of decline in global cognition and semantic memory (all p < 0.04).”

    Humansmean follow-up = 7.7 yearsn = 626

    Cerebral amyloid angiopathy, brain iron concentrations, and cognitive decline in older people

    Acta neuropathologica

White matter microstructural abnormalities

upin Saimiri1

1 study
  1. Cerebral amyloid angiopathy increases white matter microstructural abnormalities in Saimiri.

    “Multi‐shell DWI revealed abnormal propagation along the WM tract, which went undetected using conventional ARIA‐E criteria.”

    Animalsbrain

    Age‐associated changes in neuroimaging biomarkers in a non‐human primate model of cerebral amyloid angiopathy

    AAIC 2025 abstract

Inflammation

upin Cebus1

1 study
  1. Cerebral amyloid angiopathy increases inflammation in Cebus.

    “Hematoxylin & eosin staining revealed cystic microcavitation with astrocytic gliosis and hemosiderin deposit.”

    Animalsbrainfemalesn = 1

    Spontaneous cerebral amyloid angiopathy‐related intracerebral hemorrhages in aged capuchin monkey

    AAIC 2025 abstract

More on Inflammation

Intracerebral hemorrhage

upin Cebus1

1 study
  1. Cerebral amyloid angiopathy increases intracerebral hemorrhage in Cebus (spontaneous aging).

    “demonstrated an old hematoma, characterized as low foci in SWI and T2 images with central cavitation, alongside multiple smaller areas of old hemorrhage.”

    Animalsspontaneous agingbrainfemalesn = 1

    Spontaneous cerebral amyloid angiopathy‐related intracerebral hemorrhages in aged capuchin monkey

    AAIC 2025 abstract

More on Intracerebral hemorrhage

ADRA2A

downin humans1

1 study
  1. Cerebral amyloid angiopathy is linked with lower ADRA2A in humans (cerebral amyloid angiopathy).

    “significant decrease in the expression of leptomeningeal α2a and α2b adrenergic receptors in leptomeningeal vessels of CAA vs old”

    Humanscerebral amyloid angiopathyleptomeningeal vessels

    Changes in adrenergic and cholinergic receptors on human cerebral vessels. Implications for new therapeutic strategies in Alzheimer's Disease

    AAIC 2025 abstract

More on ADRA2A

CHRNA7

downin humans1

1 study
  1. Cerebral amyloid angiopathy is linked with lower CHRNA7 in humans (cerebral amyloid angiopathy).

    “significant decrease of α7 nicotinic acetylcholine receptors in the leptomeningeal vessels of CAA vs old”

    Humanscerebral amyloid angiopathyleptomeningeal vessels

    Changes in adrenergic and cholinergic receptors on human cerebral vessels. Implications for new therapeutic strategies in Alzheimer's Disease

    AAIC 2025 abstract

More on CHRNA7

Vascular dementia

upin reviews1

1 study
  1. Cerebral amyloid angiopathy increases vascular dementia.

    “CAA triggers the progression of ischemic and hemorrhagic strokes with the subsequent the development of VaD and mixed dementia.”

    Review

    Statins for vascular dementia: A hype or hope

    Neuroscience

More on Vascular dementia

Aβ deposition proportion in unit vessel

upin mice1

1 study
  1. Cerebral amyloid angiopathy increases Aβ deposition proportion in unit vessel in AD mouse model with increasing age from 8 to 14 months (13.63% to 28.80%).

    “the proportion Aβ deposition in the unit vessel can increase from 13.63% to 28.80% upon increasing the age of mice from 8 months old to 14 months old”

    Animalsin AD mouse model with increasing age from 8 to 14 monthscerebral blood vessels

    Long-Term Repeatable In Vivo Monitoring of Amyloid-β Plaques and Vessels in Alzheimer's Disease Mouse Model with Combined TPEF/CARS Microscopy

    Biomedicines

More on Aβ deposition proportion in unit vessel

Gait

downin humans1

1 study
  1. Cerebral amyloid angiopathy is linked with worse gait in humans (compared to normal controls).

    “CAA and Alzheimer disease had similarly impaired Rhythm, Pace, and Variability, and higher dual task cost than normal controls or mild cognitive impairment.”

    Humanscompared to normal controls

    Gait in Cerebral Amyloid Angiopathy

    Journal of the American Heart Association

All 11

Upstream

9

APOE

upin mice2

2 studies
  1. APOE increases cerebral amyloid angiopathy in mice (compared to WSB.APOE2/2APP/PS1).

    “Compared to WSB.APOE2/2APP/PS1, WSB.APOE4/4APP/PS1 mice had increased CAA and plaque-associated microglial area.”

    Animalscompared to WSB.APOE2/2APP/PS1brain

    WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. APOE increases cerebral amyloid angiopathy in WSB.APP/PS1 mice, compared with APOE2 and APOE3; sex-dependent effect.

    “we show that APOE4 increased the extent of CAA in WSB.APP/PS1 mice, compared to APOE2 and APOE3, but in a sex-dependent manner.”

    Animalsin WSB.APP/PS1 mice, compared with APOE2 and APOE3; sex-dependent effect

    WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized APOE alleles

    bioRxiv : the preprint server for biologyPreprint

More on APOE

Mineralized blood vessels

no changein humans1

1 study
  1. Mineralized blood vessels were not clearly linked with cerebral amyloid angiopathy in humans after covariate adjustment.

    “MBV presence was not associated with sex, ethnicity, education, APOE ε4 carrier status, or cerebral amyloid angiopathy (CAA)”

    Humansafter covariate adjustment

    Mineralized brain vessels vary by region in Alzheimer disease

    Neurobiology of aging

More on Mineralized blood vessels

WSB.APP/PS1

upin mice1

1 study
  1. WSB.APP/PS1 increases cerebral amyloid angiopathy in WSB.APP/PS1 mice.

    “WSB.APP/PS1 brains exhibited plaque deposition, CAA, transcriptomic overlap with human AD, myelin deficits, cerebrovascular/metabolic uncoupling, and altered cerebrovascular morphology.”

    Animalsin WSB.APP/PS1 micebrain

    WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits

    Alzheimer's & dementia : the journal of the Alzheimer's Association

Down syndrome

upin humans1

1 study
  1. Down syndrome is linked with higher cerebral amyloid angiopathy in humans (Down syndrome with CAA) (Thal stage 3 vs max stage 2).

    “All three DS cases with CAA reached Thal stage 3 CAA, contrasting with a maximum of stage 2 in CAA-positive sporadic AD and elderly control cases.”

    HumansDown syndrome with CAAbrainn = 3

    Unclassifiable senile plaques and extensive cerebral amyloid angiopathy involving spinal and bridging vessels in autopsied patients with Down syndrome

    Free neuropathology

More on Down syndrome

Immune response

downin humans1

1 study
  1. Immune response is linked with lower cerebral amyloid angiopathy in humans (host immune responses to CMV, evaluated via Mendelian Randomization).

    “we leveraged two-sample Mendelian Randomization to uncover causal roles for host immune responses to CMV, including limiting brain amyloidosis.”

    Humanshost immune responses to CMV, evaluated via Mendelian Randomizationbrain

    CMV titer associations with cognition and the plasma proteome implicate FLT1 and neurovascular mechanisms as potential moderators

    Journal of neuroinflammation

More on Immune response

WSB.APP/PS1 mice

upin mice1

1 study
  1. WSB.APP/PS1 mice increases cerebral amyloid angiopathy in mice (age-dependent; mild at 8 months, robust at 14 months) (mild at 8 months, robust at 14 months).

    “We show that WSB.APP/PS1 mice show mild CAA at 8M, with robust CAA being apparent at 14M.”

    Animalsage-dependent; mild at 8 months, robust at 14 months

    WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized APOE alleles

    bioRxiv : the preprint server for biologyPreprint

More on WSB.APP/PS1 mice

Atherosclerosis

upin humans1

1 study
  1. Atherosclerosis is linked with higher cerebral amyloid angiopathy in humans (severe atherosclerosis).

    “exacerbates cerebral amyloid angiopathy (CAA)”

    Humanssevere atherosclerosishippocampus

    Atherosclerosis is associated with amyloid and tau pathology via blood-brain barrier dysfunction in the hippocampus of aged human brains

    PloS one

More on Atherosclerosis

TREM2

upin mice1

1 study
  1. TREM2 increases cerebral amyloid angiopathy in mice (Tg-SwDI mice; shown by Trem2 knockout).

    “Loss of Trem2 led to a dramatic decrease in CAA and microglial association, despite a marked increase in overall brain Aβ load.”

    AnimalsTg-SwDI mice; shown by Trem2 knockoutbrain

    Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg-SwDI mice

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on TREM2

Cardiac transthyretin amyloid

no changein humans1

1 study
  1. Cardiac transthyretin amyloid was not clearly linked with cerebral amyloid angiopathy in humans (autopsy cases).

    “No significant correlation was observed between the cardiac ATTR deposition and CAA stages, or between cardiac fibrosis and AD pathologies.”

    Humansautopsy casesheart and brainn = 240

    Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study

    Brain pathology (Zurich, Switzerland)

More on Cardiac transthyretin amyloid

Associations

46

APOE

upin humans3OR 5.76

3 studies
  1. APOE is linked with a higher risk of cerebral amyloid angiopathy in amyloid-positive AD dementia, ε4/ε4 compared to ε3/ε3 (OR = 5.76, 95% CI: 4.20-7.96).

    “Cerebral amyloid angiopathy exhibited a striking ε4 dose-response (OR = 5.76, 95% CI: 4.20-7.96, p < 0.001; for ε4/ε4 compared to ε3/ε3)”

    Humansin amyloid-positive AD dementia, ε4/ε4 compared to ε3/ε3brain

    Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4

    Research squarePreprint

  2. APOE is linked with a higher risk of cerebral amyloid angiopathy in humans (longitudinally compared to reference group).

    “higher CAA risk was observed among males, older individuals, smokers, people with diabetes/heart conditions/lower MMSE scores, and APOE-ε4 carriers compared to their reference groups.”

    Humanslongitudinally compared to reference group

    Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. APOE is linked with a higher risk of cerebral amyloid angiopathy in participants with type 2 diabetes and APOE epsilon4 allele (RR 6.6, 95% CI 1.5-29.6).

    “they had a higher risk of cerebral amyloid angiopathy (RR 6.6, 1.5-29.6)”

    Humansin participants with type 2 diabetes and APOE epsilon4 allelebrainmalesn = 216

    Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

    Diabetes

More on APOE

Dementia

upin humans2no changein humans1

3 studies
  1. Cerebral amyloid angiopathy is associated with dementia in humans.

    “CAA was associated with dementia adjusted for demographics but was attenuated and no longer significant adjusting for other neuropathologies.”

    Humansn = 4,000

    Risk Factors for and Consequences of CAA in Three Community-Based Clinical-Pathologic Studies

    GSA 2025 abstract

  2. Cerebral amyloid angiopathy is associated with dementia in humans (Repetitive head impact-exposed brain donors).

    “The greatest contributors to dementia were AD, neocortical LBD, hippocampal sclerosis, cerebral amyloid angiopathy, and CTE.”

    HumansRepetitive head impact-exposed brain donorsbrainn = 571

    Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts

    Annals of neurology

  3. Cerebral amyloid angiopathy raises the risk of dementia in humans (risk difference 19%, 95% CI 3-34%).

    “CAA: 19%, 3-34%).”

    Review

    Association of lewy bodies, hippocampal sclerosis and amyloid angiopathy with dementia in community-dwelling elderly: A systematic review and meta-analysis

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

More on Dementia

Brain iron

upin humans2

2 studies
  1. Cerebral amyloid angiopathy is associated with brain iron in humans (adjusted for demographics, intermediate/high ADNC, and other pathologies) (Est = 0.033, SE = 0.011, p = 0.002).

    “the presence and severity of CAA were associated with elevated cortical brain iron (Est = 0.033, SE = 0.011, p = 0.002; Est = 0.017, SE = 0.004, p < 0.001, respectively).”

    Humansadjusted for demographics, intermediate/high ADNC, and other pathologiesinferior temporal cortexn = 626

    Cerebral amyloid angiopathy, brain iron concentrations, and cognitive decline in older people

    Acta neuropathologica

  2. Cerebral amyloid angiopathy is associated with brain iron in humans (Est=0.018, SE=0.004, p = <0.001).

    “CAA was associated with higher iron levels (Est=0.018, SE=0.004, p = <0.001).”

    Humansinferior temporal cortexn = 680

    Role of brain iron on cerebral amyloid angiopathy and decline in cognition specifically perceptual speed in older people

    AAIC 2025 abstract

More on Brain iron

Cognitive function

downin humans1downin rhesus monkeys1

2 studies
  1. Cerebral amyloid angiopathy is associated with cognitive function in humans (p <0.024).

    “both CAA and elevated iron level were independently associated with faster decline in global cognition and three cognitive domains (episodic, semantic, and perceptual speed) (all p <0.024).”

    Humansn = 680

    Role of brain iron on cerebral amyloid angiopathy and decline in cognition specifically perceptual speed in older people

    AAIC 2025 abstract

  2. Cerebral amyloid angiopathy is associated with cognitive function in rhesus monkeys.

    “monkeys at extremes of the ATN and ABC classifications, or with frequent CAA, had significantly lower scores on some cognitive tests”

    Animalsbrainn = 32

    Human Alzheimer's Disease ATN/ABC Staging Applied to Aging Rhesus Macaque Brains: Association With Cognition and MRI-Based Regional Gray Matter Volume

    The Journal of comparative neurology

Blood pressure variability

upin humans1downin humans1

1 study
  1. Blood pressure variability is associated with cerebral amyloid angiopathy in humans (adjusted for age, gender, and mean SBP) (1.29 [1.03-1.61]).

    “lower SBP range (1.29 [1.03-1.61]; P = 0.028)”

    Humansadjusted for age, gender, and mean SBP56% femalesn = 72

    Association between systolic blood pressure variability and severity of cerebral amyloid angiopathy in incident intracerebral hemorrhage

    Frontiers in stroke

  2. Cerebral amyloid angiopathy is associated with blood pressure variability in humans (pre-morbid 10 years before first-ever ICH) (14 vs. 17 mmHg, P = 0.033).

    “patients with moderate-severe CAA had similar mean SBP (143 vs. 145 mmHg, P = 0.588) but lower SBP variability (SBP standard deviation [SD] 14 vs. 17 mmHg, P = 0.033)”

    Humanspre-morbid 10 years before first-ever ICH56% femalesn = 72

    Association between systolic blood pressure variability and severity of cerebral amyloid angiopathy in incident intracerebral hemorrhage

    Frontiers in stroke

More on Blood pressure variability

Memory

downin humans1

1 study
  1. Cerebral amyloid angiopathy is associated with memory in humans (Memory β=-0.26, 95% CI -0.33 to -0.19; p<0.001).

    “CAA was strongly associated with poorer cognition across domains, including memory (β=-0.26, 95% CI -0.33 to -0.19; p<0.001).”

    Humansbrain43.3% femalesn = 1,269

    Alzheimer’s changes partly account for links to poorer thinking

    Brain : a journal of neurology

TSPAN4-positive monocytes

upin humans1

1 study
  1. Cerebral amyloid angiopathy predicts TSPAN4-positive monocytes in a small CAA cohort versus healthy controls (AUC ~0.91).

    “with an exploratory area under the ROC curve of approximately 0.91 for TSPAN4-positive monocytes versus healthy controls”

    Reviewin a small CAA cohort versus healthy controls

    Border-Associated Macrophage Migrasomes in Alzheimer's Disease: An Emerging Aβ-Senescence-Microglia Axis?

    Cells

More on TSPAN4-positive monocytes

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change

upin humans1

1 study
  1. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change is associated with cerebral amyloid angiopathy in humans (older adults).

    “Significant cerebrovascular NC associations included cerebral amyloid angiopathy and arteriosclerosis.”

    Reviewolder adults

    Clinical, genetic, and neuropathologic correlates of limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC): A systematic review and meta-analysis

    Journal of neuropathology and experimental neurology

More on Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change

USP24

mixedin humans1

1 study
  1. USP24 is associated with cerebral amyloid angiopathy in humans (post-mortem evaluation).

    “USP24 was associated with cerebral amyloid angiopathy.”

    Humanspost-mortem evaluationbone tissuefemalesn = 45

    Establishing bone tissue level changes associated with cognitive impairment

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on USP24

Down syndrome

upin humans1+84%

1 study
  1. Down syndrome is associated with cerebral amyloid angiopathy in humans (84%).

    “CAA was the most frequent co-pathology, present in approximately 84% of individuals followed by LP (21%), HS (19%), and LATE-NC (17%).”

    Humansbrainn = 63

    Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia

    Acta neuropathologica

More on Down syndrome

All 46

Trial sponsors

Funding

29 grants since 2018

National Institute on Aging$18.4MNational Institute of Neurological Disorders and Stroke$15.8MAmerican Heart Association$648K

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 25Jan 2026: 6Feb 2026: 8Mar 2026: 2Apr 2026: 5May 2026: 5Jun 2026: 5Jul 2026: 8Aug 2026: 3Sep 2026: 6Oct 2026: 7Nov 2026: 585 papers in 12 months
Neurology

Age-related brain protein changes linked to poorer cognition

The changes were linked to a 4.06-point higher dementia rating score, compared with 3.78 points for moderate or severe Alzheimer’s-related changes.The changes were linked to a 4.06-point higher dementia rating score, compared with 3.78 points for moderate or severe Alzheimer’s-related changes.

Cross-sectional · 1,860 peoplePopulations
Brain

Alzheimer’s changes partly account for links to poorer thinking

Alzheimer’s changes statistically accounted for 13–29% of small-artery thickening’s links to poorer thinking, versus 64–91% for amyloid protein buildup in brain vessels.Alzheimer’s changes statistically accounted for 13–29% of small-artery thickening’s links to poorer thinking, versus 64–91% for amyloid protein buildup in brain vessels.

Cohort · 1,269 peopleMechanisms
Acta Neuropathologica

Blood pressure decline and brain vessel disease links differ by sex

An observational study followed 2,033 older adults for 9.1 years on average, linking falling blood pressure more strongly to small-artery disease in women.An observational study followed 2,033 older adults for 9.1 years on average, linking falling blood pressure more strongly to small-artery disease in women.

Cohort · 2,033 peoplePopulations
bioRxiv

Brain scan changes linked to vessel disease in squirrel monkeys

An animal experiment compared scans with brain tissue in young and older squirrel monkeys, linking an imaging measure to amyloid vessel disease and tissue injury.An animal experiment compared scans with brain tissue in young and older squirrel monkeys, linking an imaging measure to amyloid vessel disease and tissue injury.

Preprint: cross-sectional studyBiomarkers
Alzheimer's & Dementia

Sleep's link to brain damage varies with other vessel injuries

In an observational study of 735 people, other brain vessel injuries strengthened links between shorter sleep and brain lesions in some diagnostic groups.In an observational study of 735 people, other brain vessel injuries strengthened links between shorter sleep and brain lesions in some diagnostic groups.

Cross-sectional study of 735 peoplePopulations
Annals of Neurology

Severely enlarged brain vessel spaces predicted bleeding lesions

Over a median 5.1 years, bleeding-related lesions appeared in 33.7% of participants with severe enlargement versus 13.6% without severe enlargement.Over a median 5.1 years, bleeding-related lesions appeared in 33.7% of participants with severe enlargement versus 13.6% without severe enlargement.

Cohort study of 932 peopleBiomarkers

See all 242 papers on cerebral amyloid angiopathy